文献速递肝胆胰外科

腹腔镜肝切除治疗前侧与后上段病变的比较:一项Meta分析

Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis.
PubMed 文献 · Surg Endosc · 2017-04-07

该Meta分析比较了腹腔镜肝切除(LLR)治疗位于前侧(AL)和后上段(PS)肝脏病变的手术结局。共纳入5项研究846例患者(AL组565例,PS组281例)。结果显示AL组手术时间和中转开腹率更低、切缘更宽,但两组在失血量、并发症发生率、住院时间和肿瘤复发方面无显著差异。LLR对经选择的PS段病变患者技术可行且安全。

要点

  • AL组手术时间(SMD -0.60)和中转率(OR 0.40)显著低于PS组。
  • AL组切缘宽度优于PS组(SMD 0.2,95%CI 0.03-0.37,P=0.019)。
  • 两组失血量、并发症、住院时间和肿瘤复发无显著差异。

核心结论

  • 腹腔镜肝切除对经选择的PS段病变患者技术可行且安全。

研究设计与样本

  • Meta分析,纳入5项研究共846例患者,AL组565例,PS组281例,使用STATA 12.0软件计算SMD和OR及95%CI。

主要发现

  • AL组手术时间短于PS组(SMD -0.60;95% CI -0.75至-0.45;P=0.000)。
  • AL组中转开腹率低于PS组(OR 0.40;95% CI 0.24-0.67;P=0.000)。
  • AL组切缘宽度大于PS组(SMD 0.2;95% CI 0.03-0.37;P=0.019)。
  • 两组失血量(SMD -0.29;95% CI -0.68至0.09;P=0.131)、并发症发生率(OR 0.73;95% CI 0.50-1.07;P=0.103)、住院时间(SMD -0.53;95% CI -1.16至0.11;P=0.105)和肿瘤复发(OR 1.23;95% CI 0.81-1.86;P=0.334)无显著差异。

关键数值与推荐

  • AL段包括II、III、IVb、V和VI段;PS段包括I、IVa、VII和VIII段。

临床怎么用

  • 对经选择的PS段肝脏病变患者,可考虑行腹腔镜肝切除,但需注意手术时间和中转风险可能高于AL段病变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic liver resection (LLR) is mostly performed to treat benign lesions at easily accessible locations. With improvements in instruments and accumulation of experience, LLR has evolved to treat malignant tumors with major hepatectomy, even in less accessible locations, without compromising the principles of safety and oncology. The present meta-analysis aimed to compare the outcomes of LLR for lesions located in anterolateral (AL) (II, III, IVb, V, and VI) and posterosuperior (PS) (I, IVa, VII, and VIII) liver segments. METHODS: A comprehensive search was conducted to identify all eligible studies. This meta-analysis was performed using the STATA 12.0 statistical software. Standardized mean differences (SMDs) and odds ratios (ORs) were calculated for continuous variables and dichotomous variables, respectively, with 95% confidence intervals (CIs). RESULTS: A total of 846 patients from five studies were identified for the final analysis, with 565 patients in the AL group and 281 in the PS group. Although the operation time (SMD -0.60; 95% CI -0.75 to -0.45; P = 0.000) and conversion rate (OR 0.40; 95% CI 0.24-0.67; P = 0.000) were lower and the resection margin was wider (SMD 0.2; 95% CI 0.03-0.37; P = 0.019) in the AL group than in the PS group, no significant differences in blood loss (SMD -0.29; 95% CI -0.68 to 0.09; P = 0.131), complication rate (OR 0.73; 95% CI 0.50-1.07; P = 0.103), hospital stay (SMD -0.53; 95% CI -1.16 to 0.11; P = 0.105), and tumor recurrence (OR 1.23; 95% CI 0.81-1.86; P = 0.334) were noted between the groups. CONCLUSION: LLR is technically feasible and safe for selected patients with lesions in the PS segments of the liver.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zheng B, Zhao R, Li X, et al. Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis. Surg Endosc. 2017. PMID: 28389796. doi:10.1007/s00464-017-5527-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。